• @[email protected]
    link
    fedilink
    297 months ago

    i wish that they would also reschedule lsd and psilocybin to schedule III, but at least some progress is better than no progress

      • @[email protected]
        link
        fedilink
        47 months ago

        It is arbitrary. While what classification a substance is may have some grounding in research, it’s mostly up to what interest group has either lobbied to get something under or whatever group law enforcement wants to be able to get easy charges for. Cannabis was Sched I because it made it easy for law enforcement to get big sentences for minorities and the counter culture participants of the day. Same thing with LSD and psilocybin.

        All the DEA scheduling is just pick and choose your charge for whatever ideological ax they want to grind. Hence why things don’t line up with reality

    • @[email protected]
      link
      fedilink
      87 months ago

      And MDMA? It shows a lot of promise in therapeutic use. Schedule 1 is for substances with “no currently accepted medical treatment use”.

      • @[email protected]
        link
        fedilink
        27 months ago

        Yeah, MDMA also doesn’t belong in schedule I, although it is definitely more risky than lsd and mushrooms

          • @[email protected]
            link
            fedilink
            27 months ago

            Overdose of MDMA can cause seratonin syndrome, which can be fatal; and long term use might be linked to depression and anxiety (again, by the way it interacts with seratonin)

            It definitely should be rescheduled too, since it is not dangerous enough and definitely has potential for medical use (couple therapy was it’s original use)